Sequent’s arm concludes acquisition of 60% stake in Provet

04 Nov 2014 Evaluate

Sequent Scientific’s wholly owned subsidiary, Alivira Animal Health (Alivira) has acquired 60% stake in Provet Veterinary Products AS, Turkey (Provet). The company earlier on September 10, 2014 had entered into an agreement to acquire 60% stake in Provet.

Provet is amongst top 5 in veterinary medicine providers in Turkey. With a ready portfolio of over 100 formulations, largely in the difficult space of injectibles and a newly established state-of-the-art facility which would soon be offered for EU GMP approval, Provet will accelerate Alivira’s foray in the global veterinary market.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×